135 related articles for article (PubMed ID: 37229783)
1. Association between low-income subsidies and inequities in orally administered antimyeloma therapy use.
Jazowski SA; Samuel-Ryals CA; Wood WA; Zullig LL; Trogdon JG; Dusetzina SB
Am J Manag Care; 2023 May; 29(5):246-254. PubMed ID: 37229783
[TBL] [Abstract][Full Text] [Related]
2. Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy.
Biggers A; Shi Y; Charlson J; Smith EC; Smallwood AJ; Nattinger AB; Laud PW; Neuner JM
J Clin Oncol; 2016 Dec; 34(36):4398-4404. PubMed ID: 27998232
[TBL] [Abstract][Full Text] [Related]
3. The Association Between Medicare Low-Income Subsidy and Anticancer Treatment Uptake in Advanced Lung Cancer.
Chou YT; Farley JF; Stinchcombe TE; Proctor AE; Lafata JE; Dusetzina SB
J Natl Cancer Inst; 2020 Jun; 112(6):637-646. PubMed ID: 31501872
[TBL] [Abstract][Full Text] [Related]
4. The effect of out-of-pocket costs on initiation of disease-modifying therapies among medicare beneficiaries with multiple sclerosis.
Hartung DM; Johnston KA; McGregor JC; Bourdette DN
Mult Scler Relat Disord; 2020 Nov; 46():102554. PubMed ID: 33032059
[TBL] [Abstract][Full Text] [Related]
5. Association between insurance cost-sharing subsidy and postoperative opioid prescription refills among Medicare patients.
Kirsch M; Montgomery JR; Hu HM; Englesbe M; Hallstrom B; Brummett CM; Fendrick AM; Waljee JF
Surgery; 2020 Aug; 168(2):244-252. PubMed ID: 32505547
[TBL] [Abstract][Full Text] [Related]
6. Consequences of forgoing prescription drug subsidies among low-income Medicare beneficiaries with diabetes.
Glynn A; Hernandez I; Roberts ET
Health Serv Res; 2022 Oct; 57(5):1136-1144. PubMed ID: 35430735
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Medicare Low-income Subsidy on Access to Treatment, Treatment Choice, and Oncologic Outcomes in Patients With Metastatic Prostate Cancer.
Joyce DD; Qin X; Sharma V; Boorjian SA; Barocas DA; Dusetzina SB; Moses KA
J Urol; 2023 Sep; 210(3):447-453. PubMed ID: 37341420
[TBL] [Abstract][Full Text] [Related]
8. Racial and Sex Inequities in the Use of and Outcomes After Left Ventricular Assist Device Implantation Among Medicare Beneficiaries.
Cascino TM; Somanchi S; Colvin M; Chung GS; Brescia AA; Pienta M; Thompson MP; Stewart JW; Sukul D; Watkins DC; Pagani FD; Likosky DS; Aaronson KD; McCullough JS
JAMA Netw Open; 2022 Jul; 5(7):e2223080. PubMed ID: 35895063
[TBL] [Abstract][Full Text] [Related]
9. Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid Leukemia.
Winn AN; Keating NL; Dusetzina SB
J Clin Oncol; 2016 Dec; 34(36):4323-4328. PubMed ID: 27998234
[TBL] [Abstract][Full Text] [Related]
10. Association of Medicare Part D low-income cost subsidy program enrollment with increased fill adherence to clopidogrel after coronary stent placement.
Duru OK; Edgington S; Mangione C; Turk N; Tseng CH; Kimbro L; Ettner S
Pharmacotherapy; 2014 Dec; 34(12):1230-8. PubMed ID: 25314343
[TBL] [Abstract][Full Text] [Related]
11. The unintended effects of the Medicare Part D low income subsidy.
Decarolis F
Health Policy; 2015 May; 119(5):597-603. PubMed ID: 25716285
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with medication nonadherence among Medicare low-income subsidy beneficiaries with diabetes, hypertension, and/or heart failure.
Steve Tsang CC; Browning J; Todor L; Dougherty S; Hohmeier KC; Sam Li M; Borja-Hart N; Hines LE; Wang J
J Manag Care Spec Pharm; 2021 Aug; 27(8):971-981. PubMed ID: 34337985
[No Abstract] [Full Text] [Related]
13. Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs.
Jung K; McBean AM; Kim JA
J Manag Care Pharm; 2012 Mar; 18(2):106-15. PubMed ID: 22380470
[TBL] [Abstract][Full Text] [Related]
14. The introduction of generic aromatase inhibitors and treatment adherence among Medicare D enrollees.
Neuner JM; Kamaraju S; Charlson JA; Wozniak EM; Smith EC; Biggers A; Smallwood AJ; Laud PW; Pezzin LE
J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 25971298
[TBL] [Abstract][Full Text] [Related]
15. Many Medicare Beneficiaries Do Not Fill High-Price Specialty Drug Prescriptions.
Dusetzina SB; Huskamp HA; Rothman RL; Pinheiro LC; Roberts AW; Shah ND; Walunas TL; Wood WA; Zuckerman AD; Zullig LL; Keating NL
Health Aff (Millwood); 2022 Apr; 41(4):487-496. PubMed ID: 35377748
[TBL] [Abstract][Full Text] [Related]
16. Racial and Ethnic Differences in Initiation and Discontinuation of Antidementia Drugs by Medicare Beneficiaries.
Thorpe CT; Fowler NR; Harrigan K; Zhao X; Kang Y; Hanlon JT; Gellad WF; Schleiden LJ; Thorpe JM
J Am Geriatr Soc; 2016 Sep; 64(9):1806-14. PubMed ID: 27549029
[TBL] [Abstract][Full Text] [Related]
17. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
J Manag Care Spec Pharm; 2014 Aug; 20(8):862-76. PubMed ID: 25062080
[TBL] [Abstract][Full Text] [Related]
18. Subsidising artemisinin-based combination therapy in the private retail sector.
Opiyo N; Yamey G; Garner P
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009926. PubMed ID: 26954551
[TBL] [Abstract][Full Text] [Related]
19. The Medicare drug benefit: update on the low-income subsidy.
Stahlman ME
Issue Brief George Wash Univ Natl Health Policy Forum; 2009 Jul; (833):1-22. PubMed ID: 19685590
[TBL] [Abstract][Full Text] [Related]
20. High cost sharing and specialty drug initiation under Medicare Part D: a case study in patients with newly diagnosed chronic myeloid leukemia.
Doshi JA; Li P; Huo H; Pettit AR; Kumar R; Weiss BM; Huntington SF
Am J Manag Care; 2016 Mar; 22(4 Suppl):s78-86. PubMed ID: 27270157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]